Isomer enriched conjugated linoleic acid compositions
View Patent ↗Compositions and methods of using conjugated linoleic acid preparations enriched for the t10,c12 and c9,t11 isomers are disclosed. It is found that preparations of conjugated linoleic acid containing a ratio of t10,c12 to c9,t11 of about greater than 1.2:1 are desirable for a wide variety of nutritional, therapeutic and pharmacologic uses.
1. A method of alleviating the effects of viral infection comprising:
a) providing a patient suffering from a viral infection and a composition comprising t10,c12 CLA and c9,t11 CLA in a ratio of about 1.2:1 to 3:1; and
b) administering said composition to said patient.
2. The method of claim 1 , wherein said CLA composition is administered orally.
3. The method of claim 1 , wherein said CLA composition comprises free fatty acids of t10,c12 octadecadienoic acid and c9,t11 octadecadienoic acid.
4. The method of claim 1 , wherein said CLA composition comprises esters of t10,c12 octadecadienoic acid and c9,t11 octadecadienoic acid.
5. The method of claim 1 , wherein said CLA composition comprises acylglycerides of t10,c12 octadecadienoic acid and c9,t11 octadecadienoic acid.
6. A method of alleviating the effects of administration of a vaccine comprising:
a) providing a patient to which a vaccine has been administered and a composition comprising t10,c12 CLA and c9,t11 CLA in a ratio of about 1.2:1 to 3:1; and
b) administering said composition to said patient.
7. The method of claim 6 , wherein said CLA composition is administered orally.
8. The method of claim 6 , wherein said CLA composition comprises free fatty acids of t10,c12 octadecadienoic acid and c9,t11 octadecadienoic acid.
9. The method of claim 6 , wherein said CLA composition comprises esters of t10,c12 octadecadienoic acid and c9,t11 octadecadienoic acid.
10. The method of claim 6 , wherein said CLA composition comprises acylglycerides of t10,c12 octadecadienoic acid and c9,t11 octadecadienoic acid.